1. Home
  2. ORIC

as 03-28-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 545.5M IPO Year: 2020
Target Price: $18.43 AVG Volume (30 days): 674.4K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.83 EPS Growth: N/A
52 Week Low/High: $5.78 - $14.67 Next Earning Date: 05-05-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ORIC Daily Stock ML Predictions

Share on Social Networks: